ArticleThe oncologist2020

Bevacizumab in Combination with TAS-102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study.

Hironori Fujii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.